| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/25/2005 | US20050186664 Albumin fusion proteins |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 08/25/2005 | US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression |
| 08/25/2005 | US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same |
| 08/25/2005 | CA2849552A1 Hybrid polypeptides with selectable properties |
| 08/25/2005 | CA2556568A1 Substituted pyrazoline compounds for reducing triglycerides in blood |
| 08/25/2005 | CA2556405A1 Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/25/2005 | CA2556400A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 08/25/2005 | CA2555817A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 08/25/2005 | CA2554378A1 Bicycloamide derivative |
| 08/24/2005 | EP1566384A1 Novel azole derivatives |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565468A1 Novel xanthin derivatives, production and use thereof as medicaments |
| 08/24/2005 | EP1565437A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 08/24/2005 | EP1565212A1 Gastrin compositions and formulations, and methods of use and preparation |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 08/24/2005 | EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/24/2005 | EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 08/24/2005 | EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity |
| 08/24/2005 | EP1330435B1 Crystalline forms of fluvastatin sodium |
| 08/24/2005 | EP1317413B1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 08/24/2005 | EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 08/24/2005 | EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1163218B1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| 08/24/2005 | EP1157014B1 Polycyclic 2-amino-dihydrothiazole systems, method for the production thereof and their utilization as medicament |
| 08/24/2005 | EP1144394B1 1-heterocycle substituted diarylamines |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | EP1032406B1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659182A Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
| 08/24/2005 | CN1659177A Gangliosides with a modified acyl function |
| 08/24/2005 | CN1659168A Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 08/24/2005 | CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same |
| 08/24/2005 | CN1659156A Novel guanidinobenzamides |
| 08/24/2005 | CN1659154A Method of preparing amine stereoisomers |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament |
| 08/24/2005 | CN1659137A N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use |
| 08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1658903A Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658886A Hormone replacement therapy |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1658876A A buffered, liquid nicotine composition for pulmonary administration |
| 08/24/2005 | CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 08/24/2005 | CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/24/2005 | CN1658871A Amide derivatives as GK activators |
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658868A Bazedoxifene treatment regimens |
| 08/24/2005 | CN1658867A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/24/2005 | CN1658865A Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/24/2005 | CN1658864A Stabilized ascorbic acid derivatives |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658852A Amidine derivatives for treating amyloidosis |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1657529A 2-substituted imine thia zlidine derivative its preparation technology and medicinal composition |
| 08/24/2005 | CN1657092A Formula of yixintong dripping pill and its preparation method |
| 08/24/2005 | CN1657090A Extract of prinsepia wood and its bioactivity function |
| 08/24/2005 | CN1657057A Pure natural cheap weight-reducing agent-bittern |
| 08/24/2005 | CN1657055A Traditional Chinese oral preparation of ophiopogon and coptisine and its preparation method |
| 08/24/2005 | CN1657054A Oral administration dual polysaccharide Chinese medicine and its preparation method |
| 08/24/2005 | CN1657050A Chinese medicine oral preparation for lonering blood sugar and its preparation method |
| 08/24/2005 | CN1657048A Laminaran granule and its preparation technology |
| 08/24/2005 | CN1657040A Curcumin and phosphatide composite and its preparation method |
| 08/24/2005 | CN1656933A Weight-reducing edible fibrous bablet |
| 08/24/2005 | CN1216142C Health preserving wine and its making method |
| 08/24/2005 | CN1216055C Paroxetine hydrochloride anhydrous compound and its preparation method and use |
| 08/24/2005 | CN1215868C Medicine for treating diabetes peripheral nerve affection and preparation method thereof |
| 08/24/2005 | CN1215851C Buccal tablet of Qingqian willow leaf |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933309 Halogenobenzyl aminopropionic acid derivatives |
| 08/23/2005 | US6933304 Antitumor agents, osteoporosis |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6932990 Comprises solvent extract of compressed cake derived from defatted evening primrose seed wherein effective component contains polyphenol-essential elements such as ellagic acid, gallic acid, pentagalloylglucose and catechin |
| 08/23/2005 | US6932984 Method of microencapsulation |
| 08/23/2005 | US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity |
| 08/23/2005 | CA2153235C Compounds having selectivity for retinoid x receptors |
| 08/23/2005 | CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 08/18/2005 | WO2005075641A1 Screening method |
| 08/18/2005 | WO2005075421A1 Bicycloester derivative |